RE:Not so good newsMy personal opinion was they would come in around 12-15 Million (Max). Just based on all the same info that's been made public (grow room approval, growth cycle, timing, etc).
Curious is the number you quote strictly "Rec", if so I'm sure Supreme still sales product under the "Medical" classification?